Top Markets
Coin of the day
PerkinElmer, Inc. PerkinElmer, Inc.

PerkinElmer, Inc.

PKI
Classificação em ações #1518
PerkinElmer, Inc. operates as a global enterprise delivering innovative... PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.
Preço da ação
$120.30
Última sincronização: 2023-05-23
Valor de mercado
$15.17B
Variação (1 dia)
0.05%
Variação (1 ano)
0.00%
País
US
Negociar PerkinElmer, Inc. (PKI)

Categoria

Histórico de preços das ações de PerkinElmer, Inc. (PKI)
Preço de fecho mais alto: $122.56 em 2023-05-01

Preço de fecho mais baixo: $1.36 em 1972-06-01
Histórico de preços das ações da PerkinElmer, Inc. de 1972 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 -12.81%
2022 -25.85%
2021 33.46%
2020 49.44%
2019 17.03%
2018 12.89%
2017 36.40%
2016 1.22%
2015 19.93%
2014 9.91%
2013 25.65%
2012 64.80%
2011 -25.03%
2010 26.86%
2009 36.71%
2008 -43.16%
2007 17.07%
2006 -5.35%
2005 5.39%
2004 34.38%
2003 100.53%
2002 -74.66%
2001 -36.62%
2000 146.94%
1999 52.14%
1998 39.09%
1997 -0.17%
1996 -5.71%
1995 44.32%
1994 -19.73%
1993 -5.85%
1992 -17.82%
1991 36.21%
1990 3.52%
1989 16.00%
1988 -16.81%
1987 12.92%
1986 -21.92%
1985 25.38%
1984 -7.94%
1983 17.60%
1982 39.87%
1981 -2.68%
1980 80.20%
1979 64.26%
1978 62.16%
1977 2.59%
1976 26.75%
1975 8.05%
1974 -28.71%
1973 -4.87%
1972 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$628.91 28.15%
US
$215.23 3.61%
US
$23.33 66.89%
CN
$328.08 101.93%
US
$559.16 -12.82%
US